Logos Global Management LP cut its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 40.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 800,000 shares of the company’s stock after selling 550,000 shares during the period. Apellis Pharmaceuticals accounts for approximately […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) General Counsel David O. Watson sold 8,510 shares of the firm’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $89.98, for a total value of $765,729.80. Following the completion of the transaction, the general counsel now owns 85,753 shares […]